業績亮眼 湯臣倍健(300146.SZ)大漲超13%
格隆匯3月8日丨湯臣倍健(300146.SZ)盤初最高漲13.25%報26.5元,股價創年內新高,市值超400億元。公司發佈2020年年報及一季度業績預吿,全年營收60.95億元,同比增15.83%,歸母淨利潤15.24億元,較2019年剔除商譽及無形資產減值影響後利潤同增45.71%。同時公司發佈2021年一季度業績預吿,預計2021Q1實現歸母淨利潤7.22-8.29億元,同比增35%-55%。華創發佈業績點評稱,湯臣倍健疫情影響下線下銷售維持平穩,線上增速亮眼;受投資收益及並表影響,全年業績大幅提升,一季度開門紅亦如期而至;新一輪三年增長週期啟動,看好全年快步前行;成長賽道的龍頭公司,低估值強改善下價值凸顯,維持“強推”評級,維持12個月目標價32元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.